Cargando…

Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society

BACKGROUND: There is an increasing interest in HER2-low breast cancer with promising data from clinical trials using novel anti-HER2 antibody–drug conjugates. We explored the differences in clinicopathological characteristics and survival outcomes between HER2-low and HER2-IHC 0 breast cancer. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Won, Hye Sung, Ahn, Juneyoung, Kim, Yongseon, Kim, Jin Sung, Song, Jeong-Yoon, Kim, Hong-Kyu, Lee, Jeeyeon, Park, Heung Kyu, Kim, Yong-Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935777/ https://www.ncbi.nlm.nih.gov/pubmed/35307014 http://dx.doi.org/10.1186/s13058-022-01519-x

Ejemplares similares

Analysis of Genomic Alterations Associated with Recurrence in Early Stage HER2-Positive Breast Cancer
por: Kim, Yong-Seok, et al.
Publicado: (2022)

Relationship Between Breast and Axillary Pathologic Complete Response According to Clinical Nodal Stage: A Nationwide Study From Korean Breast Cancer Society
por: Ryu, Jai Min, et al.
Publicado: (2022)

The Basic Facts of Korean Breast Cancer in 2011: Results of a Nationwide Survey and Breast Cancer Registry Database
por: Kim, Zisun, et al.
Publicado: (2014)

Erratum: The Basic Facts of Korean Breast Cancer in 2011: Results of a Nationwide Survey and Breast Cancer Registry Database
por: Kim, Zisun, et al.
Publicado: (2015)

The Basic Facts of Korean Breast Cancer in 2013: Results of a Nationwide Survey and Breast Cancer Registry Database
por: Min, Sun Young, et al.
Publicado: (2016)

Subcutaneous implantation of thyroid carcinoma and benign tissue after thyroidectomy: report on two cases and review of the current literature
por: Kim, Yongseon, et al.
Publicado: (2023)

Survival Outcomes of Patients With Breast Cancer Diagnosed Using Vacuum-Assisted Biopsy: A Nationwide Study From the Korean Breast Cancer Society
por: Kim, Bong Kyun, et al.
Publicado: (2021)

The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database
por: Kim, Zisun, et al.
Publicado: (2015)

Survey of the Application of the Korean Clinical Practice Recommendations on Breast Cancer Treatment: The Utility of the Korean Breast Cancer Society Guidelines
por: Gwak, Geumhee, et al.
Publicado: (2012)

Clinicopathological features and prognosis associated with breast cancer laterality: a nationwide study from the Korean Breast Cancer Society
por: Kim, Bong Kyun, et al.
Publicado: (2022)

Characteristics of BRCA1/2 Mutation-Positive Breast Cancers in Korea: A Comparison Study Based on Multicenter Data and the Korean Breast Cancer Registry
por: Yu, Jong-Han, et al.
Publicado: (2014)

Quality Assessment and Trend for Breast Cancer Treatment Practice across South Korea Based on Nationwide Analysis of Korean Health Insurance Data during 2013–2017
por: Choi, Kyu Hye, et al.
Publicado: (2023)

Omission of Chemotherapy for the Treatment of Mucinous Breast Cancer: A Nationwide Study from the Korean Breast Cancer Society
por: Kim, Hyung Suk, et al.
Publicado: (2019)

A Nationwide Survey of Knowledge of and Compliance with Cancer Pain Management Guidelines by Korean Physicians
por: Kim, Do Yeun, et al.
Publicado: (2014)

Association of EGFR mutations in second primary lung cancer and HER2 expression in breast cancer survivors
por: Jang, Yoon Jung, et al.
Publicado: (2021)

Nation-Wide Korean Breast Cancer Data from 2008 Using the Breast Cancer Registration Program
por: Jung, Yong Sik, et al.
Publicado: (2011)

Predictive biological factors for late survival in patients with HER2-positive breast cancer
por: Kang, Young-Joon, et al.
Publicado: (2023)

Prognostic Significance of HER2 Gene Amplification According to Stage of Breast Cancer
por: Kim, Yong-Seok, et al.
Publicado: (2008)

Erratum: Nation-Wide Korean Breast Cancer Data from 2008 Using the Breast Cancer Registration Program
por: Jung, Yong Sik, et al.
Publicado: (2012)

Development of second primary cancer in Korean breast cancer survivors
por: Jung, Hong Kyu, et al.
Publicado: (2017)

Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
por: Kim, Joo Heung, et al.
Publicado: (2021)

Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer
por: Kim, Yun Gyoung, et al.
Publicado: (2017)

The reality in the follow-up of breast cancer survivors: survey of Korean Breast Cancer Society
por: Kim, Ku Sang, et al.
Publicado: (2015)

Author Correction: Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
por: Kim, Joo Heung, et al.
Publicado: (2023)

Effects of Temperature and Pressure on Acute Stroke Incidence Assessed Using a Korean Nationwide Insurance Database
por: Lim, Jae-Sung, et al.
Publicado: (2017)

Differences in clinical outcomes between HER2-negative and HER2-positive luminal B breast cancer
por: Kang, Byeongju, et al.
Publicado: (2023)

Mastectomy with Reconstruction Including Robotic Endoscopic Surgery (MARRES): a prospective cohort study of the Korea Robot-Endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG) and Korean Breast Cancer Study Group (KBCSG)
por: Ryu, Jai Min, et al.
Publicado: (2023)

Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer
por: Kwak, Yoonjin, et al.
Publicado: (2017)

Fertility preservation for patients with breast cancer: The Korean Society for Fertility Preservation clinical guidelines
por: Kim, Hoon, et al.
Publicado: (2017)

Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer
por: Kim, Yun Yeong, et al.
Publicado: (2018)

Changing Patterns in the Clinical Characteristics of Korean Breast Cancer from 1996-2010 Using an Online Nationwide Breast Cancer Database
por: Ko, Beom Seok, et al.
Publicado: (2012)

A Nationwide Study on the Incidence of Breast Cancer in Korean Women with Osteoporosis Receiving Raloxifene Treatment
por: Lee, Jihyoun, et al.
Publicado: (2021)

Survival After Development of Contralateral Breast Cancer in Korean Patients With Breast Cancer
por: Kim, Hakyoung, et al.
Publicado: (2023)

Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy
por: Park, Jeong Hyun, et al.
Publicado: (2018)

The value of chest CT for prediction of breast tumor size: comparison with pathology measurement
por: Ahn, Su Joa, et al.
Publicado: (2013)

HER2+ breast cancer treatment and cardiotoxicity: monitoring and management
por: Jerusalem, Guy, et al.
Publicado: (2019)

Dosimetric comparison of simultaneous integrated boost with whole-breast irradiation for early breast cancer
por: Son, Seok Hyun, et al.
Publicado: (2017)

Five-Year Overall Survival of Interval Breast Cancers is Better than Non- Interval Cancers from Korean Breast Cancer Registry
por: Lee, Jung Sun, et al.
Publicado: (2019)

A nationwide, multicenter retrospective study on the effectiveness and safety of eribulin in Korean breast cancer patients (REMARK)
por: Park, Min Ho, et al.
Publicado: (2020)

Clinical Significance of Substaging and HER2 Expression in Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary Bladder
por: Lim, So Dug, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q5vk6p1n6ctt176onibcu4uqsr